Farther Finance Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95K | Sell |
62
-90
| -59% | -$2.84K | ﹤0.01% | 3700 |
|
|
2025
Q1 | $4.82K | Buy |
152
+37
| +32% | +$1.17K | ﹤0.01% | 3080 |
|
|
2024
Q4 | $4.16K | Sell |
115
-20
| -15% | -$723 | ﹤0.01% | 2744 |
|
|
2024
Q3 | $4.21K | Sell |
135
-20
| -13% | -$624 | ﹤0.01% | 2710 |
|
|
2024
Q2 | $4.12K | Buy |
155
+61
| +65% | +$1.62K | ﹤0.01% | 2482 |
|
|
2024
Q1 | $3.15K | Sell |
94
-33
| -26% | -$1.11K | ﹤0.01% | 2291 |
|
|
2023
Q4 | $3.68K | Buy |
127
+57
| +81% | +$1.65K | ﹤0.01% | 2125 |
|
|
2023
Q3 | $1.93K | Buy |
70
+5
| +8% | +$138 | ﹤0.01% | 1869 |
|
|
2023
Q2 | $1.95K | Hold |
65
| – | – | ﹤0.01% | 1762 |
|
|
2023
Q1 | $2.36K | Hold |
65
| – | – | ﹤0.01% | 1580 |
|
|
2022
Q4 | $2.32K | Buy |
+65
| New | +$2.32K | ﹤0.01% | 1401 |
|